Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), IDISNA, Pamplona, Spain.
CIBER of Frailty and Healthy Aging (CIBERFES), Institute of Health Carlos III, Madrid, Spain.
J Hum Nutr Diet. 2022 Oct;35(5):968-979. doi: 10.1111/jhn.12962. Epub 2021 Nov 15.
There is limited evidence on the role of an anti-/pro-inflammatory diet in the prevention of non-alcoholic fatty liver disease (NAFLD). We aimed (i) to assess the anti-inflammatory diet profile and its association with transient elastography parameters, including liver stiffness measurement (LSM) and controlled attenuation parameter (CAP), and (ii) to analyse the relationship between the anti-inflammatory diet and surrogate markers of liver disease in a multiethnic US population.
A cross-sectional study was conducted on a nationally representative population of 4189 US adults aged 20-80 years. A FibroScan® 502 V2 device (Echosens) was used to estimate the CAP and LSM. Liver markers, including the aspartate transaminase (AST) to alanine transaminase (ALT) ratio, fatty liver index (FLI) and fibrosis-4 score, were also calculated. The Dietary Inflammatory Index (DII) was calculated using a 24-h diet recall.
Lower DII scores (anti-inflammatory diet) were associated with a lower AST:ALT ratio (p < 0.001) and FLI (p < 0.036) after adjusting for covariates. Linear regression analysis revealed that gamma-glutamyl transferase levels (β = 1.702, 95% confidence interval [CI] = 0.325-3.080, p = 0.015), ALT levels (β = -0.616, 95% CI = -1.097 to -0.135, p = 0.012), AST:ALT ratio (β = 0.025, 95% CI = 0.014-0.036, p < 0.001) and FLI (β = 1.168, 95% CI = 0.224-2.112, p = 0.015) were significantly associated with the DII in the multivariable-adjusted model. Participants in the highest anti-inflammatory tertile had the lowest odds ratio (OR) for NAFLD assessed by FLI in both unadjusted (OR = 0.652, 95% CI = 0.539-0.788, p ≤ 0.001) and adjusted models (OR = 0.722, 95% CI = 0.537-0.972, p = 0.032). For the transient elastography parameters (LSM and CAP), no significant associations were identified.
There was no relationship between the transient elastography parameters and the anti-inflammatory diet profile, although our study showed an association between higher pro-inflammatory properties of diet and poorer hepatic health assessed by surrogate markers of liver disease. Therefore, strategies to promote an anti-inflammatory diet should be considered to prevent NAFLD in adults.
关于抗炎/促炎饮食在非酒精性脂肪性肝病(NAFLD)预防中的作用,目前的证据有限。我们旨在(i)评估抗炎饮食模式及其与瞬时弹性成像参数(包括肝硬度测量值[LSM]和受控衰减参数[CAP])的相关性,以及(ii)在一个多民族的美国人群中分析抗炎饮食与肝脏疾病替代标志物之间的关系。
对 4189 名年龄在 20-80 岁的美国成年人进行了一项全国代表性的横断面研究。使用 FibroScan® 502 V2 设备(Echosens)来估计 CAP 和 LSM。还计算了肝标志物,包括天冬氨酸转氨酶(AST)与丙氨酸转氨酶(ALT)比值、脂肪肝指数(FLI)和纤维化-4 评分。使用 24 小时膳食回顾来计算饮食炎症指数(DII)。
在调整了协变量后,较低的 DII 评分(抗炎饮食)与较低的 AST:ALT 比值(p<0.001)和 FLI(p<0.036)相关。线性回归分析显示,谷氨酰转移酶水平(β=1.702,95%置信区间[CI]为 0.325-3.080,p=0.015)、ALT 水平(β=-0.616,95%CI 为-1.097 至-0.135,p=0.012)、AST:ALT 比值(β=0.025,95%CI 为 0.014-0.036,p<0.001)和 FLI(β=1.168,95%CI 为 0.224-2.112,p=0.015)与多元调整模型中的 DII 显著相关。在未调整(OR=0.652,95%CI=0.539-0.788,p≤0.001)和调整模型(OR=0.722,95%CI=0.537-0.972,p=0.032)中,FLI 评估的 NAFLD 患者中,DII 最高 tertile 的参与者具有最低的比值比(OR)。
瞬时弹性成像参数与抗炎饮食模式之间没有关联,但我们的研究表明,饮食的促炎特性与肝脏疾病的替代标志物评估的较差肝脏健康之间存在关联。因此,应该考虑促进抗炎饮食的策略,以预防成年人的 NAFLD。